▲ 0.18%
prev close
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
+1
1 buys · 0 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-12-05 | BNTXBioNTech SE - American Depositary Shares | Buy | $1,001 - $15,000 | 927d ago | — |
2023-12-05
Josh Gottheimer
BNTX
Amount
$1,001 - $15,000
Filed
927d ago
Recent News
Powered by Polygon.io
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
BioNTech veröffentlicht am 4. August 2026 Ergebnisse für das zweite Quartal 2026 und informiert über operativen Fortschritt
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now
Trade Timeline
Congressional activity, newest first
Josh Gottheimer
2023-12-05 · Purchase
$1,001 - $15,000